PIM
ABBV icon

Profit Investment Management’s AbbVie ABBV Stock Holding History

Profit Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$987K Hold
4,320
– – 3.99% 7
2025
Q3 		$1M Sell
4,320
-1,723
-29% -$351K 1.26% 36
2025
Q2 		$1.12M Hold
6,043
– – 1.01% 43
2025
Q1 		$1.27M Sell
6,043
-200
-3% -$38.9K 1.18% 35
2024
Q4 		$1.11M Sell
6,243
-238
-4% -$43.8K 0.89% 48
2024
Q3 		$1.28M Sell
6,481
-227
-3% -$42.4K 1.01% 47
2024
Q2 		$1.15M Hold
6,708
– – 0.72% 44
2024
Q1 		$1.22M Hold
6,708
– – 0.69% 46
2023
Q4 		$1.04M Hold
6,708
– – 0.6% 50
2023
Q3 		$1,000K Sell
6,708
-255
-4% -$37.4K 0.71% 42
2023
Q2 		$938K Sell
6,963
-167
-2% -$24.5K 0.61% 47
2023
Q1 		$1.14M Sell
7,130
-1,473
-17% -$225K 0.75% 40
2022
Q4 		$1.39M Hold
8,603
– – 0.98% 34
2022
Q3 		$1.16M Sell
8,603
-202
-2% -$29K 0.88% 36
2022
Q2 		$1.35M Hold
8,805
– – 0.99% 32
2022
Q1 		$1.43M Hold
8,805
– – 0.88% 35
2021
Q4 		$1.19M Buy
+8,805
New +$1.04M 0.75% 40
2015
Q2 		– Sell
-67,593
Closed -$3.96M – 127
2015
Q1 		$3.96M Hold
67,593
– – 0.21% 63
2014
Q4 		$4.42M Buy
67,593
+26,560
+65% +$1.67M 0.22% 59
2014
Q3 		$2.37M Sell
41,033
-13,113
-24% -$728K 0.12% 85
2014
Q2 		$3.06M Sell
54,146
-453,559
-89% -$23.8M 0.15% 81
2014
Q1 		$26.1M Sell
507,705
-202,340
-28% -$10.2M 1.18% 41
2013
Q4 		$37.5M Sell
710,045
-68,333
-9% -$3.36M 1.71% 26
2013
Q3 		$34.8K Buy
778,378
+170,762
+28% +$7.57M 1.43% 30
2013
Q2 		$25.1M Buy
+607,616
New +$26.6M 1.21% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Profit Investment Management's ABBV Position: Q4 2025 in Review

Profit Investment Management held its AbbVie (ABBV) position steady in Q4 2025 at 4,320 shares worth $987K. The position accounts for 3.99% of the portfolio, ranked #7.

Profit Investment Management first reported a position in ABBV in Q2 2013 and has held it in 25 quarters since. The position peaked at $37.5M in Q4 2013. 4,155 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Profit Investment Management held 4,320 shares of AbbVie worth $987K as of Q4 2025.
  • Profit Investment Management left its AbbVie share count unchanged in Q4 2025.
  • AbbVie made up 3.99% of Profit Investment Management's portfolio in Q4 2025, its #7 holding.
  • Profit Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 25 quarters since.
  • Profit Investment Management's AbbVie position peaked at $37.5M in Q4 2013.
  • 4,155 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Profit Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.